Handelsavisen
prelaunch
Companies Healthcare 4021.SE
40
4021.SE Tadawul Healthcare Facilities & Services

Canadian General Medical Center Complex Company SJSC

$5,24
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
2,24 %
Op margin
12,2 %
ROE
10,9 %
Net margin
7,1 %
Debt / equity
0,06
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Canadian General Medical Center Complex Company SJSC operates in the healthcare facilities and services industry, providing medical services and pharmaceuticals to its patients and clients.

Business. Canadian General Medical Center Complex Company SJSC (4021.SE) is a healthcare facilities and services provider engaged in pharmaceutical activities. The company is headquartered in Saudi Arabia and is primarily listed on the Tadawul exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityPharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
10,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 4021.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 4021.SE. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Canadian General Medical Center Complex Company SJSC (4021.SE) is a healthcare facilities and services provider engaged in pharmaceutical activities. The company is headquartered in Saudi Arabia and is primarily listed on the Tadawul exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityPharmaceuticals
    AI synthesis
    GENERATED

    The company maintains a strong liquidity position, with a current ratio of 4.0, indicating that it has four times more current assets than current liabilities. However, its free cash flow is negative at -41,310, which may signal short-term cash flow constraints despite positive operating cash flow of 19,875,690. The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.06, suggesting that it is not heavily leveraged.

    Profitability metrics show a return on equity of 10.93% and a return on assets of 7.89%, both of which are strong indicators of efficient use of equity and assets. These figures are in line with the industry's preferred metrics, which emphasize asset efficiency and return generation. The company's operating income of 18,108,230 and net income of 10,496,890 reflect a healthy margin, although the gross profit of 43,492,360 suggests that cost management is a key area of focus.

    Geographically and segment-wise, the company's revenue concentration is not disclosed in the available data, but the absence of segment-specific revenue breakdowns implies that it may operate as a single business unit or that its segments are not publicly differentiated. This lack of segmentation could limit the ability to assess the performance of individual business lines or geographic regions.

    The company's growth trajectory is not explicitly outlined in the available data, but the capital expenditure of -9,356,530 indicates a reduction in investment in long-term assets, which may suggest a focus on cost containment or a shift in strategic priorities. The absence of forward-looking guidance in the data makes it difficult to assess the company's future growth prospects.

    Risk factors include a medium liquidity risk, as the company's free cash flow is negative and its net cash position is negative after subtracting total debt. The dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted shares. The company's conservative capital structure and strong liquidity position mitigate some of these risks.

    Recent events and filings are not detailed in the available data, but the company's financial performance and risk profile suggest that it is maintaining a stable position in the healthcare sector. The absence of recent significant events or disclosures does not necessarily indicate a lack of activity, but rather a lack of public information in the provided dataset.

    Key takeaways
    • The company has a strong liquidity position with a current ratio of 4.0.
    • It maintains a conservative capital structure with a low debt-to-equity ratio of 0.06.
    • Profitability is robust, with a return on equity of 10.93% and a return on assets of 7.89%.
    • Free cash flow is negative, indicating potential short-term cash flow constraints.
    • The company's growth trajectory is unclear due to a lack of forward-looking guidance and reduced capital expenditures.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $5,24
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $96.1M
    Net cash
    -$6.0M
    Current ratio
    4.0
    Debt / equity
    0.1
    ROA
    7.9%
    ROE
    10.9%
    Cash conversion
    189.0%
    CapEx / revenue
    -6.3%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin12,2 %Above median
    Net Margin7,1 %Above median
    ROE10,9 %Above median
    Capex / Rev-6,3 %Above median
    D/E0,06Above P75
    Cash Conv1,89Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Canadian General Medical Center Complex Company SJSC Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    4021.SECanonical
    Tadawul · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage